Theory Based SMS Reminders - Text's Impact on Patient Attendance

Status Not yet recruiting

Clinical Trial Summary

The project will be done at the ear, nose and throat outpatient department at Lovisenberg Diakonale Hospital (LDS) in 2015-2016. About 12% of patients with appointments at the surgical outpatient clinic at LDS do not attend their appointment even after receiving both letters and shot message service (SMS) reminders. Persuasion theory suggests that the SMS reminders may be more effective if the text appeals more to the patient's feelings. The project is designed as a randomized controlled trial in which the control group receives the standard text that has neutral content and the intervention group receives a more emotion-based SMS reminder. The aim is to determine whether the more emotional text reduces the proportion of patients who do not show up for their scheduled appointment at the surgical outpatient clinic.

Clinical Trial Description

Studies from Norway's Health South East (HSØ) show that the number of patients who do not attend their scheduled appointments account for 200 000 to 250 000 outpatient consultations each year. For comparison, there are 270,000 patients waiting for treatment. It has thus been recommended that regional health authorities take measures to reduce the number of patients who do not attend their scheduled appointment.

This study will evaluate whether short message service (SMS) appointment reminders that appeal to the patient's emotions are more effective for reducing non-attendance to scheduled outpatient appointments at the ear, nose, and throat outpatient clinic at Lovisenberg Diakonale Hospital in Oslo, Norway. The study will be designed as randomized controlled trial in which 2000 patients are randomly assigned to either the intervention group (emotional SMS text) or the control group (standard SMS text with neutral content). Because theory suggests that emotion-based text messages will be more effective reminders, it is hypothesized that they will result in a 50% reduction in the number of patients who do not show for their appointment compared to the control group. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Health Services Research

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02453633
Study type	Interventional
Source	Lovisenberg Diakonale Hospital
Contact	Trude von Trepka
Phone	+47 23226862
Email	trvt@lds.no
Status	Not yet recruiting
Phase	N/A
Start date	May 2015
Completion date	August 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02188498` - Electrocardiography Data Analysis in Sleep Disorders
Completed	`NCT00990106` - Augmentation Trial of Prazosin for Post-Traumatic Stress Disorder (PTSD)	N/A
Completed	`NCT00942253` - Exercise Training in Dialysis Patients With Restless Legs Syndrome (RLS)	Phase 2
Completed	`NCT00163670` - The Impact of Sleep Disorders on Motor Vehicle Accidents	N/A
Completed	`NCT00256685` - Study Evaluating DVS-233 SR to Treat Vasomotor Systems Associated With Menopause	Phase 3
Completed	`NCT00203827` - Pediatric Sleep Questionnaire: Use for Collection of Clinical Data	N/A
Completed	`NCT00174174` - Provigil (Modafinil) Study by Taiwan Biotech Co.	N/A
Terminated	`NCT00750919` - Twenty-six Week Extension Trial of Org 50081 (Esmirtazapine) in Outpatients With Chronic Primary Insomnia (176003/P05721/MK-8265-007)	Phase 3
Completed	`NCT02939586` - The Effect of Haemodialysis in Sleep Apnoea	N/A
Completed	`NCT03075241` - Z-Drugs for Sleep Disorders in Alzheimer's Disease	Phase 3
Completed	`NCT03055156` - Effect of High Rebound Mattress Toppers on Sleep and Sleep-Related Symptoms	N/A
Completed	`NCT02585609` - Sleep Quality in Patients With Advanced Cancer	N/A
Completed	`NCT01906866` - Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities	Phase 3
Completed	`NCT01929447` - Evaluation of WP200 With the Unified Probe (WP200U)	N/A
Completed	`NCT02156128` - Subjective Memory Complaints, Objective Memory Performance and Cognitive Training	N/A
Completed	`NCT01528462` - Sleep Disorders Managed and Assessed Rapidly in Transient Ischemic Attack (TIA) and In Early Stroke
Completed	`NCT01220401` - Efficacy of a Brief Nightmare Treatment for Veterans	N/A
Completed	`NCT01256983` - Light for Renal Transplant Recipients Having a Sleep-Wake Dysregulation	Phase 0
Not yet recruiting	`NCT00749814` - Sleep Disturbances in Hospitalized Children	Phase 4
Completed	`NCT00518986` - Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and Depression	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.